Urine Testing in
Asymptomatic Patients
UPDATE: Amendments to MBS for Urine Testing in Asymptomatic Patients
Published July 2025
From 1 July 2025, the Medicare Benefits Schedule (MBS) item for urine testing (69333) will be amended. This amendment stipulates that urine testing and examination (including serial examinations) are only required when symptoms of a urinary tract infection or kidney disease are present.
Practitioners are encouraged to consult the most up-to-date guidelines on the indications of urinary tract infection or kidney disease. At the time of publishing, this may include not only pain with urination and frequency of urination, but also systemic presentations such as suspected sepsis, delirium or fever of unknown origin.
Exception to this amendment is made for specified patient groups who may be asymptomatic, including those who are:
- Pregnant
- Less than 16 years of age
- Recipients of renal transplants
- Suffering from recurrent urinary tract infections
- Being investigated or monitored for kidney disease
- Undergoing urinary tract instrumentation, urological procedures or transurethral resection of the prostate
If you enjoyed this article, subscribe to our electronic Pathology Focus newsletter.
Related Pages
Long COVID
Associate Professor Chris Barnes outlines laboratory investigations to support diagnosis and management of patients with suspected Long COVID.
STI Case Studies
Explore Clinical Labs case studies on systemic manifestations of STIs, highlighting atypical presentations of gonorrhoea and syphilis and the importance of early detection in general practice.
STI Testing
Clinical guidelines for STI testing in asymptomatic patients, including opportunistic screening strategies and recommendations for managing co-infections.